CBLL (CeriBell) Interest Expense : $-1.04 Mil (TTM As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is CeriBell Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. CeriBell's interest expense for the three months ended in Sep. 2024 was $ -0.53 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was $-1.04 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. CeriBell's Operating Income for the three months ended in Sep. 2024 was $ -9.94 Mil. CeriBell's Interest Expense for the three months ended in Sep. 2024 was $ -0.53 Mil. CeriBell did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CeriBell Interest Expense Historical Data

The historical data trend for CeriBell's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CeriBell Interest Expense Chart

CeriBell Annual Data

Trend

Dec22

Dec23

Interest Expense

-1.60

-2.10

CeriBell Quarterly Data
	Dec22	Jun23	Sep23	Dec23	Jun24	Sep24
Interest Expense	Get a 7-Day Free Trial			-	-0.53	-0.51	-	-0.53

CeriBell Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.04 Mil.

CeriBell (NAS:CBLL) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CeriBell's Interest Expense for the three months ended in Sep. 2024 was $-0.53 Mil. Its Operating Income for the three months ended in Sep. 2024 was $-9.94 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was $21.10 Mil.

CeriBell's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

CeriBell did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

CeriBell Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CeriBell Inc (NAS:CBLL) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

360 N. Pastoria Avenue, Sunnyvale, CA, USA, 94085

Website

https://www.ceribell.com

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.